RBC Capital Keeps Their Buy Rating on Next plc (NXT)
In a report released on January 21, Richard Chamberlain from RBC Capital maintained a Buy rating on Next plc (NXT – Research Report), with a ...
Axsome Therapeutics (AXSM) Gets a Buy from RBC Capital
RBC Capital analyst Leonid Timashev maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) on January 21 and set a price ...
RBC Capital Sticks to Its Buy Rating for Sarepta Therapeutics (SRPT)
In a report released on January 21, Brian Abrahams from RBC Capital maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), ...
RBC Capital Reaffirms Their Buy Rating on Coursera (COUR)
In a report released on January 20, Rishi Jaluria from RBC Capital maintained a Buy rating on Coursera (COUR – Research Report), with a price ...
RBC Capital Remains a Sell on 3M (MMM)
In a report released yesterday, Deane Dray from RBC Capital maintained a Sell rating on 3M (MMM – Research Report), with a price target of ...